(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 4.95% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.33%.
Bausch & Lomb's revenue in 2025 is $4,791,000,000.On average, 7 Wall Street analysts forecast BLCO's revenue for 2025 to be $1,763,877,006,310, with the lowest BLCO revenue forecast at $1,759,322,731,154, and the highest BLCO revenue forecast at $1,767,641,041,940. On average, 5 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,859,256,308,649, with the lowest BLCO revenue forecast at $1,825,129,028,768, and the highest BLCO revenue forecast at $1,877,772,304,504.
In 2027, BLCO is forecast to generate $1,951,725,612,096 in revenue, with the lowest revenue forecast at $1,886,740,923,908 and the highest revenue forecast at $1,989,326,844,143.